RenovaCare Clinical Trial to Start at U.S. Burn Centers
June 07, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...
FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial
May 06, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that its Investigational Device Exemption (IDE) application has been granted...
RenovaCare Announces Organizational Changes and Appointment of New Officers
March 30, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
February 25, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference
January 08, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
December 22, 2020 08:00 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
November 19, 2020 08:15 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020
October 22, 2020 16:35 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference
September 15, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
August 11, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...